Blog

2024 Governor’s Business Plan Contest: Check out 13 of 25 finalists

Read More

A Quad Chart and its use

Read More

Tackling NSF SBIR/STTR Proposals

Read More

Not Your Typical SBIR Award. Air Force Hacks SBIR to Promote More Small Business Participation

It’s been three years in the making, and now the Air Force’s AFWERX program is pronouncing they are out of startup mode.

Sum Up Your USDA SBIR Commercialization Plan with a Financial Projections Table

The USDA has a deadline coming up in October for submission of Phase I SBIR proposals.

NSF Project Pitch

For those of you interested in NSF applications, note that there have been some significant changes in the last year.

AirForce Innovation: What is Innovation?

The Department of Defense has the largest SBIR budget.

Tackling Your SBIR Budget

Dr. Mooneyham is representing, Superior Medical Experts, a new Service Provider approved by CTC to support Wisconsin companies to submit competitive SBIRs.

A Bridge to Commercial Success- SBIR Phase IIB

Almost all of the big commercial successes from the National Science Foundation SBIR/STTR program have been companies that received Phase IIB awards, according to Ben Schrag, Senior Program Director of SBIR/STTR at NSF.

Finding a (not always obvious) Funding Fit for Medical Technology

We often work with clients who are developing a technology best suited for a medical application.

NSF Commercialization Plan Tips & Pitfalls

In a Quick Chat earlier this month, the Senior Program Director for SBIR/STTR programs at the NSF – Ben Schrag – shared a few best practices for preparing commercialization plans.

Are you Thinking Like a Small Business or a Research Program?

The Center for Technology Commercialization (CTC) hosted BBC etc for a special training on accessing the Department of Defense (DoD) funding.

Plumb Pharma wins 2020 Governor’s Business Plan Contest

Congratulations to Plumb Pharma — CTC client and SBIR Advance awardee — on winning the 2020 Governor’s Business Plan Contest! Plumb Pharma of Madison has developed a platform technology for super-extended-release medications that extends release 3-5 times longer than current medications.